WallStreetZenWallStreetZen

NASDAQ: ISRG
Intuitive Surgical Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for ISRG

Based on 11 analysts offering 12 month price targets for Intuitive Surgical Inc

Min Forecast
$440.00-14.07%
Avg Forecast
$606.36+18.42%
Max Forecast
$688.00+34.36%

Should I buy or sell ISRG stock?

Based on 11 analysts offering ratings for Intuitive Surgical Inc.

Buy
Strong Buy
6 analysts 54.55%
Buy
3 analysts 27.27%
Hold
1 analysts 9.09%
Sell
0 analysts 0%
Strong Sell
1 analysts 9.09%
Although ISRG's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates ISRG as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their ISRG stock forecasts and price targets.

ISRG stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-07-08
lockedlocked$00.00+00.00%2025-06-09
lockedlocked$00.00+00.00%2025-05-22Find Out Why
lockedlocked$00.00+00.00%2025-04-24
lockedlocked$00.00+00.00%2025-04-23
Truist Securities
Top 7%
94
Strong BuyMaintains$590.00+15.22%2025-04-23
Piper Sandler
Top 16%
85
Strong BuyMaintains$575.00+12.29%2025-04-23
Baird
Top 20%
81
BuyMaintains$575.00+12.29%2025-04-23
Raymond James
Top 14%
87
BuyMaintains$688.00+34.36%2025-01-24
Wells Fargo
Top 16%
85
Strong BuyMaintains$687.00+34.16%2025-01-24

1 of 2

Forecast return on equity

Is ISRG forecast to generate an efficient return?

Company
N/A
Industry
8.73%
Market
89.88%

Forecast return on assets

Is ISRG forecast to generate an efficient return on assets?

Company
N/A
Industry
5.33%

ISRG earnings per share forecast

What is ISRG's earnings per share in the next 3 years based on estimates from 10 analysts?

Avg 1 year Forecast
$6.23-10.3%
Avg 2 year Forecast
$7.35+5.78%
Avg 3 year Forecast
$8.35+20.07%
ISRG's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

ISRG revenue forecast

What is ISRG's revenue in the next 3 years based on estimates from 11 analysts?

Avg 1 year Forecast
$9.7B+10.75%
Avg 2 year Forecast
$11.1B+27.45%
Avg 3 year Forecast
$12.7B+46.17%
ISRG's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ISRG earnings growth forecast

How is ISRG forecast to perform vs Medical Instruments & Supplies companies and vs the US market?

Company
6.55%
Industry
15.68%
Market
15.82%
ISRG's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
ISRG's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
ISRG's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

ISRG revenue growth forecast

How is ISRG forecast to perform vs Medical Instruments & Supplies companies and vs the US market?

Company
13.35%
Industry
10.08%
Market
10.4%
ISRG's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ISRG's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ISRG vs Medical Stocks

TickerPricePrice TargetUp/downsideConsensus
ISRG$512.06$606.36+18.42%Buy
BDX$175.97$215.33+22.37%Strong Buy
ALC$87.48$112.50+28.60%Strong Buy
RMD$254.40$265.86+4.50%Buy
WST$227.18$281.67+23.98%Buy
View Top Medical Stocks

Intuitive Surgical Stock Forecast FAQ

Is Intuitive Surgical Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 11 Wall Street analysts covering (NASDAQ: ISRG) stock is to Buy ISRG stock.

Out of 11 analysts, 6 (54.55%) are recommending ISRG as a Strong Buy, 3 (27.27%) are recommending ISRG as a Buy, 1 (9.09%) are recommending ISRG as a Hold, 0 (0%) are recommending ISRG as a Sell, and 1 (9.09%) are recommending ISRG as a Strong Sell.

If you're new to stock investing, here's how to buy Intuitive Surgical stock.

What is ISRG's earnings growth forecast for 2025-2027?

(NASDAQ: ISRG) Intuitive Surgical's forecast annual earnings growth rate of 6.55% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast earnings growth rate of 15.68%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.82%.

Intuitive Surgical's earnings in 2025 is $2,476,100,000.On average, 10 Wall Street analysts forecast ISRG's earnings for 2025 to be $2,234,379,402, with the lowest ISRG earnings forecast at $2,182,767,173, and the highest ISRG earnings forecast at $2,308,213,562. On average, 10 Wall Street analysts forecast ISRG's earnings for 2026 to be $2,635,091,011, with the lowest ISRG earnings forecast at $2,444,412,499, and the highest ISRG earnings forecast at $2,738,315,468.

In 2027, ISRG is forecast to generate $2,991,000,338 in earnings, with the lowest earnings forecast at $2,985,624,064 and the highest earnings forecast at $2,996,376,612.

What is ISRG's revenue growth forecast for 2025-2027?

(NASDAQ: ISRG) Intuitive Surgical's forecast annual revenue growth rate of 13.35% is forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 10.08%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.4%.

Intuitive Surgical's revenue in 2025 is $8,714,900,000.On average, 11 Wall Street analysts forecast ISRG's revenue for 2025 to be $3,459,452,997,260, with the lowest ISRG revenue forecast at $3,419,704,412,781, and the highest ISRG revenue forecast at $3,494,219,567,995. On average, 11 Wall Street analysts forecast ISRG's revenue for 2026 to be $3,981,149,046,744, with the lowest ISRG revenue forecast at $3,905,683,724,735, and the highest ISRG revenue forecast at $4,103,763,573,361.

In 2027, ISRG is forecast to generate $4,565,612,734,716 in revenue, with the lowest revenue forecast at $4,339,361,211,247 and the highest revenue forecast at $4,735,063,566,805.

What is ISRG's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: ISRG) forecast ROA is N/A, which is lower than the forecast US Medical Instruments & Supplies industry average of 5.33%.

What is ISRG's Price Target?

According to 11 Wall Street analysts that have issued a 1 year ISRG price target, the average ISRG price target is $606.36, with the highest ISRG stock price forecast at $688.00 and the lowest ISRG stock price forecast at $440.00.

On average, Wall Street analysts predict that Intuitive Surgical's share price could reach $606.36 by Jul 8, 2026. The average Intuitive Surgical stock price prediction forecasts a potential upside of 18.42% from the current ISRG share price of $512.06.

What is ISRG's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: ISRG) Intuitive Surgical's current Earnings Per Share (EPS) is $6.95. On average, analysts forecast that ISRG's EPS will be $6.23 for 2025, with the lowest EPS forecast at $6.09, and the highest EPS forecast at $6.44. On average, analysts forecast that ISRG's EPS will be $7.35 for 2026, with the lowest EPS forecast at $6.82, and the highest EPS forecast at $7.64. In 2027, ISRG's EPS is forecast to hit $8.35 (min: $8.33, max: $8.36).

What is ISRG's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: ISRG) forecast ROE is N/A, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.